Amphastar Pharmaceuticals, Inc. (AMPH) News

Amphastar Pharmaceuticals, Inc. (AMPH): $41.88

0.10 (-0.24%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add AMPH to Watchlist
Sign Up

Filter AMPH News Items

AMPH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AMPH News Highlights

  • AMPH's 30 day story count now stands at 13.
  • Over the past 22 days, the trend for AMPH's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • The most mentioned tickers in articles about AMPH are TOP, DRUG and ABR.

Latest AMPH News From Around the Web

Below are the latest news stories about AMPHASTAR PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMPH as an investment opportunity.

Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?

Here is how Arch Therapeutics, Inc. (ARTH) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.

Yahoo | December 27, 2023

Wall Street Analysts Think Amphastar (AMPH) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Yahoo | December 27, 2023

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics

Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics are part of the Zacks top Analyst Blog.

Yahoo | December 27, 2023

Zacks.com featured highlights include Amphastar Pharmaceuticals, Shift4 Payments, Beacon Roofing Supply, Hooker Furnishings and Hilltop Holdings

Amphastar Pharmaceuticals, Shift4 Payments, Beacon Roofing Supply, Hooker Furnishings and Hilltop Holdings are part of the Zacks Screen of the Week article.

Yahoo | December 27, 2023

3 Stocks at the Forefront of Medical Innovation

Boring businesses and industries typically show new faces when technology comes around; today, these biotech stocks are leading the way.

Gabriel Osorio-Mazzilli on InvestorPlace | December 26, 2023

What Awaits These 4 Drug Stocks That More Than Doubled in 2023?

Here are four drug, biotech stocks, AMPH, DERM, CNTA & AQST, which have more than doubled in 2023 with room for further growth in 2024.

Yahoo | December 26, 2023

5 Good Opportunities on Relative Price Strength Strategy

AMPH, FOUR, BECN, HOFT and HTH are five stocks with explosive relative price strength.

Yahoo | December 26, 2023

3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock

Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Yahoo | December 25, 2023

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.

Yahoo | December 21, 2023

Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?

AMPH stock has doubled so far this year and is in a buy zone again. It earlier bought Eli Lilly's emergency diabetes drug which can drive future growth.

Yahoo | December 21, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!